The Executive Trap
Why founders and executives are the most concentrated — and the most constrained
If you're a founder, C-suite executive, or early employee of a publicly traded company, you are almost certainly in the most dangerous concentration scenario possible: your human capital (salary, bonus, RSU grants) and your financial capital (vested stock, exercised options) are both tied to the same company. A corporate downturn doesn't just reduce your portfolio — it threatens your income, your unvested equity, and potentially your job simultaneously.
The problem is compounded by regulatory constraints. As an insider, you can't simply log into your brokerage and sell. You're subject to blackout windows, pre-clearance requirements, Section 16 short-swing profit rules, and — since the 2023 SEC amendments — mandatory cooling-off periods for 10b5-1 trading plans. These constraints create a paradox: the people who most need to diversify are the least able to do it quickly.
Founder Who Diversified at IPO+1yr vs. Founder Who Held 100%
Held 100% Through 2021–2022
-62%
Average peak-to-trough decline for tech insiders who held
Among founders and executives of major tech companies who held 90%+ of their position through the 2021–2022 drawdown, the average peak-to-trough decline was 62%. Many experienced 75%+ declines. Unrealized gains built over years evaporated in months.
Diversified 50% Within First Year Post-IPO
-18%
Average portfolio decline with 50% diversified
Founders who diversified 50% of their position within the first year post-IPO (using 10b5-1 plans, exchange funds, or §721 contributions) experienced an average portfolio decline of just 18% during the same period. The diversified half buffered the concentrated half.
Rule 10b5-1 Plans
The 2023 SEC amendments changed everything — here's what's new
Rule 10b5-1 trading plans allow corporate insiders to pre-schedule stock sales at a time when they do not possess material nonpublic information (MNPI). Once adopted, the plan executes automatically — buying or selling at predetermined prices, dates, or formulas. The plan provides an affirmative defense against insider trading claims. In December 2022, the SEC adopted significant amendments (effective February 27, 2023) that tightened the rules substantially.
| Rule 10b5-1 Provision | Pre-2023 (Old Rules) | Post-2023 (Current Rules) |
|---|---|---|
| Cooling-off period (officers/directors) | None required | 90 days or until next 10-Q/10-K filing (whichever is later), max 120 days |
| Cooling-off period (non-officers) | None required | 30 days |
| Single-trade plans | Unlimited | One single-trade plan per 12 months |
| Overlapping plans | Permitted | Prohibited — cannot have multiple active plans |
| Certification requirement | None | Must certify not in possession of MNPI at adoption |
| Company disclosure | Minimal | Quarterly disclosure of plan adoption/termination on Form 10-Q/10-K |
| Plan modifications | Frequent modifications permitted | Modification treated as termination + new plan (new cooling-off period) |
SEC Enforcement Focus: The SEC has explicitly stated that the 2023 amendments were adopted because of 'concerns about the potential for abuse' of 10b5-1 plans. The Commission cited academic research showing abnormal returns around plan adoptions and modifications. Enforcement actions targeting suspicious 10b5-1 plan timing have increased since the amendments. Any plan that appears designed to trade on the basis of known upcoming events — even if technically compliant — may attract SEC scrutiny.
Section 16 & Blackouts
Short-swing profits, Form 4 filings, and trading windows
Section 16 of the Securities Exchange Act of 1934 applies to officers, directors, and beneficial owners of more than 10% of a company's equity securities. It imposes three key obligations: (1) beneficial ownership reporting on Forms 3, 4, and 5; (2) the short-swing profit rule under Section 16(b), which requires disgorgement of profits from any purchase-and-sale (or sale-and-purchase) within a six-month window; and (3) trading restrictions during company-imposed blackout periods under Regulation BTR.
Form 4 filing — within 2 business days of any change in beneficial ownership
Every stock sale, option exercise, RSU vesting, gift, or transfer by a Section 16 insider must be reported on SEC Form 4 within two business days. Late filings are disclosed in the company's proxy statement. This means every 10b5-1 plan execution is publicly visible almost immediately.
Section 16(b) short-swing profit rule — 6-month matching period
If you buy and sell (or sell and buy) company stock within any six-month period, the company can recover the 'profit' — even if you actually lost money on a net basis. The SEC matches the highest sale price with the lowest purchase price in the window. RSU vestings can be treated as purchases for 16(b) purposes unless exempted under Rule 16b-3.
Blackout windows — typically 2–4 weeks before earnings
Most public companies impose trading blackout periods beginning approximately two weeks before the end of each fiscal quarter and ending 1–2 business days after earnings release. Some companies impose additional blackouts around M&A activity, restatements, or material events. During blackout periods, insiders cannot trade — even under 10b5-1 plans that were adopted before the blackout (for plans adopted under the new rules, the cooling-off period typically extends past any pending blackout).
Pre-clearance — company legal/compliance must approve each transaction
Most public companies require insiders to obtain pre-clearance from the legal or compliance department before any transaction in company securities — including the adoption or modification of 10b5-1 plans, gifts of stock, and contributions to partnerships or trusts. The pre-clearance process typically takes 1–3 business days and may be denied if the company anticipates a blackout or material event.
The Embark Strategy
Generate Income on Your Appreciated Stock — Without a Tax Event
Engineers at Google, Meta & Apple use Embark’s IRS §721 strategy to generate 10%+ targeted income on concentrated positions — keep your stock, participate in upside, with no taxable event.
See if Embark fits your situation. No spam, unsubscribe anytime.
Post-IPO Timeline
The optimal diversification sequence after your company goes public
The window after an IPO is simultaneously the most important and the most constrained time for founder/executive diversification. Lockup expirations create selling pressure, but they also create the first opportunity to implement a plan. Here's the typical timeline and optimal action at each stage.
Lockup Period — No Sales Permitted
Standard underwriter lockup is 90–180 days. During this period, focus on planning: engage a tax advisor, evaluate §721 SPV vs. exchange fund vs. 10b5-1 plan, and begin the pre-clearance conversation with company counsel. No stock can be sold or transferred.
Lockup Expiration — First Window Opens
If your lockup is 90 days, this is your first opportunity. Adopt a 10b5-1 plan during an open trading window — but remember the 90-day cooling-off period (officers/directors) before any trades execute. Alternatively, initiate a §721 SPV contribution, which is not a sale and may not be subject to the same lockup restrictions (verify with company counsel).
First 10b5-1 Trades Execute
If you adopted a 10b5-1 plan at lockup expiry with a 90-day cooling-off period, your first scheduled trades begin executing around month 9–12. Each execution triggers a Form 4 filing within 2 business days. Plan to sell 10–20% of your position over the first year via the plan.
Diversify 30–50% via Multiple Channels
Combine 10b5-1 plan sales (10–20%) with a §721 SPV contribution (20–30%) for income generation and tax deferral. The §721 contribution is not a sale and defers 100% of capital gains. Consider a GRAT funded with company stock for estate planning if the TCJA exemption sunset is relevant to your estate.
Reach Target Allocation
By year 3–5 post-IPO, aim to have reduced your concentrated position to 25% or less of investable assets. The remaining position can be held with protective puts or collar strategies for downside protection. Income from the §721 SPV can fund a direct indexing portfolio for ongoing tax-loss harvesting.
§721 for Executives
Why an in-kind contribution may be the most executive-friendly strategy
A §721 contribution to a partnership is not a sale under securities law. You are contributing property (stock) to a partnership in exchange for a partnership interest. This distinction has several important implications for corporate insiders.
The Embark Approach
Not a 'Sale' Under Securities Law
Contribution ≠ sale — different regulatory treatment than 10b5-1 transactions
$0 Tax at Contribution
IRC §721(a) — full nonrecognition of gain at contribution
Income Without Selling
Partnership runs overlay strategies on contributed stock
No Cooling-Off Period
Not a 10b5-1 plan — no 90-day mandatory waiting period
Important caveats: (1) Company pre-clearance may still be required for any transfer of company securities, including contributions to partnerships — always verify with your compliance team. (2) If you are a Section 16 insider, the contribution may need to be reported on Form 4 as a disposition — but as a bona fide gift or contribution, not a sale. (3) The partnership should be structured to avoid constructive sale treatment under IRC §1259. (4) For RSU strategy considerations specific to tech employees, see our RSU Strategy guide.
FAQ
Executive Diversification — Answered
Can executives diversify their stock while employed at the company?
Yes, but within regulatory constraints. Executives must comply with insider trading laws, company blackout windows, pre-clearance requirements, and Section 16 rules. The primary mechanisms are: (1) 10b5-1 trading plans adopted during open windows with the required cooling-off period, (2) §721 contributions to partnerships (not a sale under securities law), and (3) hedging strategies like collars or protective puts (though some companies restrict these).
What is the new 10b5-1 cooling-off period?
Under the December 2022 SEC amendments (effective February 27, 2023), officers and directors must wait at least 90 days after adopting a 10b5-1 plan before the first trade executes — or until after the filing of the company's next Form 10-Q or 10-K (whichever is later), up to a maximum of 120 days. Non-officer employees must wait 30 days. Any modification to an existing plan triggers a new cooling-off period.
Is a §721 contribution considered a 'sale' for insider trading purposes?
A §721 contribution to a partnership is a contribution of property, not a sale. However, the exact securities law treatment depends on the specific facts and the company's insider trading policy. Most companies require pre-clearance for any disposition of company securities, including contributions. The contribution is not a constructive sale under IRC §1259 if the partnership maintains appropriate risk exposure to the contributed stock. Always verify with company counsel and a securities attorney before proceeding.
How long after IPO can insiders typically sell?
Standard underwriter lockup periods are 90–180 days post-IPO. After the lockup expires, insiders can trade during open windows subject to pre-clearance and 10b5-1 plan requirements. With the new 90-day cooling-off period, the earliest a 10b5-1 plan adopted at lockup expiry would execute is approximately 180–270 days post-IPO. Some companies negotiate early lockup releases for specific executives.
What is the Section 16(b) short-swing profit rule?
Section 16(b) of the Securities Exchange Act requires that any 'profit' realized by an officer, director, or 10%+ beneficial owner from a purchase and sale (or sale and purchase) of company equity within any six-month period must be disgorged to the company. The SEC matches the highest sale price with the lowest purchase price in the window — not actual transaction pairs. RSU vestings can be treated as 'purchases' for 16(b) purposes unless the grant satisfies the Rule 16b-3 exemption.
Can I use a GRAT to transfer concentrated stock to my heirs?
Yes. A Grantor Retained Annuity Trust (GRAT) allows you to transfer the future appreciation of your concentrated stock to your heirs with minimal or zero gift tax. You contribute stock to the GRAT, receive annuity payments back over the trust term (typically 2–3 years), and any appreciation above the §7520 hurdle rate passes to your beneficiaries tax-free. GRATs are particularly effective for executives who expect their stock to appreciate — and especially valuable before the 2026 estate tax exemption sunset. See our Estate Planning guide.
Executive Holding Concentrated Stock?
Diversify Within Your Compliance Framework
A §721 SPV contribution is not a sale — it's a contribution of property to a partnership under IRC §721(a). It does not trigger Section 16 reporting requirements or constructive sale treatment. Embark structures each contribution with legal counsel to ensure full compliance.